Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07623902 · ClinicalTrials.gov registry record · NA
Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population
A NA study, sponsored by Jubaan.
- Recruiting
- Registry status
- NA
- Development phase
- 1,436
- Enrollment target
NCT07623902 is a NA study that is actively recruiting participants, run by Jubaan. The registered enrollment target is 1,436 participants.
The verdict
NCT07623902, a NA study, is actively recruiting participants, sponsored by Jubaan.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,436 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if the Gixam device effectively identifies persons with pre-cancer or cancer in the colon and rectum in adults aged 45-84 that are of average risk to develop colorectal cancer and have received a negative result on a Fecal Immunochemical Test (FIT). The main questions it aims to answer are: 1. Is the Gixam Device effective in identifying persons with pre-cancer or cancer in the colon and rectum that have received a negative FIT result? 2. Is the use of the Gixam device safe? Gixam test result will be compared to the findings of a standard of care screening colonoscopy. Study participants will: 1. Undergo the Gixam test 2. Take a FIT at home and ship to a laboratory. 3. Undergo a standard of care screening colonoscopy.
Interventions
- DIAGNOSTIC_TEST FIT
- DEVICE Gixam System
- PROCEDURE Standard of care screening colonoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,436 participants |
| Start Date | 2026-05-18 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07623902
The ClinicalTrials.gov registry entry for NCT07623902 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,436 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jubaan, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which FIT is the first listed.
NCT07623902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07623902 about?
NCT07623902 is a clinical study titled "Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population". The goal of this clinical trial is to learn if the Gixam device effectively identifies persons with pre-cancer or cancer in the colon and rectum in adults aged 45-84 that are of average risk to develop colorectal cancer and have received a negative result on a Fecal Immunochemical Test (FIT). The ma...
What is the current status of trial NCT07623902?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,436 participants. The study started on 2026-05-18. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT07623902?
The interventions under investigation include: FIT (DIAGNOSTIC_TEST), Gixam System (DEVICE), Standard of care screening colonoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT07623902?
This trial is sponsored by Jubaan, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.